HRES 1285 · 119th Congress
Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
This bill hasn't been enriched yet — fetch cosponsors, actions, subjects, titles, and summaries from Congress.gov.
Why?
Every bill carries a core record (title, sponsor, latest action) that Concord fetches up front. The detailed sections — cosponsors, action history, subjects, titles, and summaries — live behind separate Congress.gov endpoints, so they're fetched on demand rather than for all 50,000+ bills at once. Until a bill has been enriched, those sections stay empty.
Brief
Executive summary
AI-generated
No executive summary yet — generate one to distill the facts below into a few sentences.
- Sponsor
- Diana DeGette
- Policy area
- Health
- Introduced
- 2026-05-14
- Chamber
- House
Status
2026-05-14 —
Referred to the House Committee on Energy and Commerce.
Coalition
0 cosponsors
(0 original)
0 actions on file
0 recorded votes
No CRS summary available for this bill.
Latest action
2026-05-14 — Referred to the House Committee on Energy and Commerce.
Summaries
Summaries not yet fetched.
Sponsor
Diana DeGetteCosponsors
Cosponsors not yet fetched.
Vote history
No votes recorded for this bill yet.
Action history
Action history not yet fetched.
Subjects
Subjects not yet fetched.
Titles
Titles not yet fetched.